EMERGENT BIOSOLUTIONS INC. Selling, General and Administrative Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Selling, General and Administrative Expense of $44.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $44.60M, a 2.06% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $46.60M, a 11.07% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $51.10M, a 15.95% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $38.90M, a 49.22% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for fiscal 2025 was $186.10M, a 39.58% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for fiscal 2024 was $308.00M, a 16.40% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for fiscal 2023 was $368.40M, a 8.51% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. selling, general and administrative expense for fiscal 2022 was $339.50M, a 2.64% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $44.60M 10-Q · filed 2026-08-06 | $91.20M 10-Q · filed 2026-08-06 | $142.30M derived: sum of 3 quarters · filed 2026-08-06 | $181.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $46.60M 10-Q · filed 2026-05-01 | $97.70M derived: sum of 2 quarters · filed 2026-05-01 | $136.60M derived: sum of 3 quarters · filed 2026-05-01 | $180.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $51.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $90.00M derived: sum of 2 quarters · filed 2026-02-27 | $133.70M derived: sum of 3 quarters · filed 2026-08-06 | $186.10M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $38.90M 10-Q · filed 2025-10-30 | $82.60M derived: sum of 2 quarters · filed 2026-08-06 | $135.00M 10-Q · filed 2025-10-30 | $195.80M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $43.70M 10-Q · filed 2026-08-06 | $96.10M 10-Q · filed 2026-08-06 | $156.90M derived: sum of 3 quarters · filed 2026-08-06 | $233.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $52.40M 10-Q · filed 2026-05-01 | $113.20M derived: sum of 2 quarters · filed 2026-05-01 | $189.80M derived: sum of 3 quarters · filed 2026-05-01 | $275.70M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $60.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $137.40M derived: sum of 2 quarters · filed 2026-02-27 | $223.30M derived: sum of 3 quarters · filed 2026-02-27 | $308.00M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $76.60M 10-Q · filed 2025-10-30 | $162.50M derived: sum of 2 quarters · filed 2025-10-30 | $247.20M 10-Q · filed 2025-10-30 | $336.90M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $85.90M 10-Q · filed 2025-08-07 | $170.60M 10-Q · filed 2025-08-07 | $260.30M derived: sum of 3 quarters · filed 2026-02-27 | $346.30M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $84.70M 10-Q · filed 2025-05-08 | $174.40M derived: sum of 2 quarters · filed 2026-02-27 | $260.40M derived: sum of 3 quarters · filed 2026-02-27 | $351.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $89.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $175.70M derived: sum of 2 quarters · filed 2026-02-27 | $267.10M derived: sum of 3 quarters · filed 2026-02-27 | $368.40M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $86.00M 10-Q · filed 2024-11-07 | $177.40M derived: sum of 2 quarters · filed 2024-11-07 | $278.70M 10-Q · filed 2024-11-07 | $372.10M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $91.40M 10-Q · filed 2024-08-07 | $192.70M 10-Q · filed 2024-08-07 | $191.90M 10-Q · filed 2023-08-09 | $286.10M derived: sum of 3 quarters · filed 2025-03-04 | $367.90M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2023-03-31 | $101.30M 10-Q · filed 2024-05-02 | $100.50M 10-Q · filed 2023-05-10 | $194.70M derived: sum of 2 quarters · filed 2025-03-04 | $276.50M derived: sum of 3 quarters · filed 2025-03-04 | $357.60M derived: sum of 4 quarters · filed 2025-03-04 | |||
| 2022-12-31 | $93.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $175.20M derived: sum of 2 quarters · filed 2025-03-04 | $256.30M derived: sum of 3 quarters · filed 2025-03-04 | $339.50M 10-K · filed 2025-03-04 | $340.30M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $81.80M 10-Q · filed 2023-12-11 | $80.20M 10-Q · filed 2022-11-09 | $162.90M derived: sum of 2 quarters · filed 2023-12-11 | $246.10M 10-Q · filed 2023-12-11 | $342.20M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-06-30 | $81.10M 10-Q · filed 2023-08-09 | $165.90M 10-Q · filed 2023-08-09 | $260.40M derived: sum of 3 quarters · filed 2024-03-08 | $342.50M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $84.80M 10-Q · filed 2023-05-10 | $179.30M derived: sum of 2 quarters · filed 2024-03-08 | $261.40M derived: sum of 3 quarters · filed 2024-03-08 | $352.60M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $94.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $176.60M derived: sum of 2 quarters · filed 2024-03-08 | $267.80M derived: sum of 3 quarters · filed 2024-03-08 | $348.70M 10-K · filed 2024-03-08 | $348.40M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $82.10M 10-Q · filed 2022-11-09 | $173.30M derived: sum of 2 quarters · filed 2022-11-09 | $254.20M 10-Q · filed 2022-11-09 | $337.10M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $91.20M 10-Q · filed 2022-08-02 | $172.10M 10-Q · filed 2022-08-02 | $255.00M derived: sum of 3 quarters · filed 2023-12-11 | $330.50M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $80.90M 10-Q · filed 2022-04-29 | $163.80M derived: sum of 2 quarters · filed 2023-12-11 | $239.30M derived: sum of 3 quarters · filed 2023-12-11 | $315.30M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $82.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $158.40M derived: sum of 2 quarters · filed 2023-12-11 | $234.40M derived: sum of 3 quarters · filed 2023-12-11 | $304.10M 10-K/A · filed 2023-12-11 | $303.30M 10-K · filed 2021-02-19 | |||
| 2020-09-30 | $75.50M 10-Q · filed 2021-11-05 | $151.50M derived: sum of 2 quarters · filed 2021-11-05 | $221.20M 10-Q · filed 2021-11-05 | $293.40M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $76.00M 10-Q · filed 2021-07-30 | $145.70M 10-Q · filed 2021-07-30 | $217.90M derived: sum of 3 quarters · filed 2022-02-25 | $282.90M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $69.70M 10-Q · filed 2021-04-30 | $141.90M derived: sum of 2 quarters · filed 2022-02-25 | $206.90M derived: sum of 3 quarters · filed 2022-02-25 | $277.70M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $72.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $137.20M derived: sum of 2 quarters · filed 2022-02-25 | $208.00M derived: sum of 3 quarters · filed 2022-02-25 | $273.50M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $65.00M 10-Q · filed 2020-11-06 | $135.80M derived: sum of 2 quarters · filed 2020-11-06 | $201.30M 10-Q · filed 2020-11-06 | $281.90M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $70.80M 10-Q · filed 2020-07-31 | $136.40M 10-Q · filed 2020-07-31 | $216.90M derived: sum of 3 quarters · filed 2021-02-19 | $259.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $65.40M 10-Q · filed 2020-05-01 | $146.10M derived: sum of 2 quarters · filed 2021-02-19 | $188.20M derived: sum of 3 quarters · filed 2021-02-19 | $227.70M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $80.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $122.80M derived: sum of 2 quarters · filed 2021-02-19 | $162.30M derived: sum of 3 quarters · filed 2021-02-19 | $202.50M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $42.10M 10-Q · filed 2019-11-07 | $42.10M 10-Q · filed 2018-11-02 | $81.60M derived: sum of 2 quarters · filed 2019-11-07 | $121.80M 10-Q · filed 2019-11-07 | $121.81M 10-Q · filed 2018-11-02 | $162.98M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $39.50M 10-Q · filed 2019-08-02 | $39.51M 10-Q · filed 2018-08-03 | $79.70M 10-Q · filed 2019-08-02 | $79.71M 10-Q · filed 2018-08-03 | $120.88M derived: sum of 3 quarters · filed 2020-02-25 | $155.38M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $40.00M 10-Q · filed 2019-05-08 | $40.20M 10-Q · filed 2018-05-04 | $81.38M derived: sum of 2 quarters · filed 2020-02-25 | $115.88M derived: sum of 3 quarters · filed 2020-02-25 | $147.75M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $41.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $75.88M derived: sum of 2 quarters · filed 2020-02-25 | $107.75M derived: sum of 3 quarters · filed 2020-02-25 | $142.90M 10-K · filed 2020-02-25 | $143.50M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $34.50M 10-Q · filed 2018-11-02 | $66.37M derived: sum of 2 quarters · filed 2018-11-02 | $101.52M 10-Q · filed 2018-11-02 | $136.29M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $31.87M 10-Q · filed 2018-08-03 | $67.02M 10-Q · filed 2018-08-03 | $101.79M derived: sum of 3 quarters · filed 2019-02-22 | $142.48M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $35.15M 10-Q · filed 2018-05-04 | $69.92M derived: sum of 2 quarters · filed 2019-02-22 | $110.61M derived: sum of 3 quarters · filed 2019-02-22 | $146.53M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $34.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $75.46M derived: sum of 2 quarters · filed 2019-02-22 | $111.39M derived: sum of 3 quarters · filed 2019-02-22 | $143.10M 10-K · filed 2019-02-22 | $143.69M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $40.69M 10-Q · filed 2017-11-03 | $76.61M derived: sum of 2 quarters · filed 2017-11-03 | $108.33M 10-Q · filed 2017-11-03 | $143.21M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $35.92M 10-Q · filed 2017-08-04 | $44.15M 10-Q · filed 2016-08-05 | $67.64M 10-Q · filed 2017-08-04 | $83.93M 10-Q · filed 2016-08-05 | $102.52M derived: sum of 3 quarters · filed 2018-02-23 | $128.32M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $31.71M 10-Q · filed 2017-05-05 | $39.78M 10-Q · filed 2016-05-06 | $66.59M derived: sum of 2 quarters · filed 2018-02-23 | $92.39M derived: sum of 3 quarters · filed 2018-02-23 | $128.85M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $34.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $60.68M derived: sum of 2 quarters · filed 2018-02-23 | $97.14M derived: sum of 3 quarters · filed 2018-02-23 | $121.14M 10-K · filed 2018-02-23 | $148.46M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $25.80M 10-Q · filed 2016-11-09 | $31.56M 10-Q · filed 2015-11-06 | $62.25M derived: sum of 2 quarters · filed 2016-11-09 | $86.26M 10-Q · filed 2016-11-09 | $102.50M 10-Q · filed 2015-11-06 | $114.40M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $36.45M 10-Q · filed 2016-08-05 | $70.95M 10-Q · filed 2016-08-05 | $88.60M derived: sum of 3 quarters · filed 2017-02-28 | $118.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $34.49M 10-Q · filed 2016-05-06 | $52.15M derived: sum of 2 quarters · filed 2017-02-28 | $82.44M derived: sum of 3 quarters · filed 2017-02-28 | $113.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $17.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $47.95M derived: sum of 2 quarters · filed 2017-02-28 | $78.50M derived: sum of 3 quarters · filed 2017-02-28 | $108.59M 10-K · filed 2017-02-28 | $122.84M 10-K · filed 2015-03-09 | |||
| 2014-09-30 | $30.29M 10-Q · filed 2015-11-06 | $60.85M derived: sum of 2 quarters · filed 2015-11-06 | $90.94M 10-Q · filed 2015-11-06 | $116.33M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $30.55M 10-Q · filed 2015-08-06 | $60.64M 10-Q · filed 2015-08-06 | $86.04M derived: sum of 3 quarters · filed 2016-02-29 | $108.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $30.09M 10-Q · filed 2015-05-08 | $55.49M derived: sum of 2 quarters · filed 2016-02-29 | $77.44M derived: sum of 3 quarters · filed 2016-02-29 | $97.94M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $25.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $47.35M derived: sum of 2 quarters · filed 2016-02-29 | $67.86M derived: sum of 3 quarters · filed 2016-02-29 | $87.88M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $21.95M 10-Q · filed 2014-11-10 | $42.46M derived: sum of 2 quarters · filed 2014-11-10 | $62.48M 10-Q · filed 2014-11-10 | $81.96M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $20.50M 10-Q · filed 2014-08-08 | $40.53M 10-Q · filed 2014-08-08 | $60.01M derived: sum of 3 quarters · filed 2015-03-09 | $79.16M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $20.03M 10-Q · filed 2014-05-12 | $39.50M derived: sum of 2 quarters · filed 2015-03-09 | $58.66M derived: sum of 3 quarters · filed 2015-03-09 | $76.55M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $19.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $38.63M derived: sum of 2 quarters · filed 2015-03-09 | $56.53M derived: sum of 3 quarters · filed 2015-03-09 | $76.02M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $19.16M 10-Q · filed 2013-11-08 | $37.05M derived: sum of 2 quarters · filed 2013-11-08 | $56.54M 10-Q · filed 2013-11-08 | $74.80M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $17.89M 10-Q · filed 2013-08-06 | $37.39M 10-Q · filed 2013-08-06 | $55.64M derived: sum of 3 quarters · filed 2014-03-10 | $73.07M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $19.49M 10-Q · filed 2013-05-03 | $37.75M derived: sum of 2 quarters · filed 2014-03-10 | $55.18M derived: sum of 3 quarters · filed 2014-03-10 | $75.56M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $18.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $35.69M derived: sum of 2 quarters · filed 2014-03-10 | $56.07M derived: sum of 3 quarters · filed 2014-03-10 | $74.28M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $17.43M 10-Q · filed 2012-11-01 | $37.82M derived: sum of 2 quarters · filed 2012-11-01 | $56.03M 10-Q · filed 2012-11-01 | $77.70M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-06-30 | $20.38M 10-Q · filed 2012-08-03 | $38.60M 10-Q · filed 2012-08-03 | $60.27M derived: sum of 3 quarters · filed 2013-03-08 | $80.96M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-03-31 | $18.21M 10-Q · filed 2012-05-04 | $39.88M derived: sum of 2 quarters · filed 2013-03-08 | $60.58M derived: sum of 3 quarters · filed 2013-03-08 | $78.22M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2010-12-31 | $21.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $42.36M derived: sum of 2 quarters · filed 2013-03-08 | $60.01M derived: sum of 3 quarters · filed 2013-03-08 | $76.20M 10-K · filed 2013-03-08 | ||||
| 2010-09-30 | $20.69M 10-Q · filed 2011-11-04 | $38.34M derived: sum of 2 quarters · filed 2011-11-04 | $54.53M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $17.65M 10-Q · filed 2011-08-05 | $33.84M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $73.79M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |